WO2020132820A1 - Synthesis method for 3-(benzyloxy)-4-oxo-4h-pyran-2-carboxylic acid - Google Patents
Synthesis method for 3-(benzyloxy)-4-oxo-4h-pyran-2-carboxylic acid Download PDFInfo
- Publication number
- WO2020132820A1 WO2020132820A1 PCT/CN2018/123144 CN2018123144W WO2020132820A1 WO 2020132820 A1 WO2020132820 A1 WO 2020132820A1 CN 2018123144 W CN2018123144 W CN 2018123144W WO 2020132820 A1 WO2020132820 A1 WO 2020132820A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- pyran
- benzyloxy
- oxo
- carboxylic acid
- Prior art date
Links
- KJSJBKBZMGSIPT-UHFFFAOYSA-N 4-oxo-3-phenylmethoxypyran-2-carboxylic acid Chemical compound O1C=CC(=O)C(OCC=2C=CC=CC=2)=C1C(=O)O KJSJBKBZMGSIPT-UHFFFAOYSA-N 0.000 title claims abstract description 38
- 238000001308 synthesis method Methods 0.000 title abstract 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 63
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 27
- 150000001875 compounds Chemical class 0.000 claims description 26
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 claims description 24
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 claims description 21
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical group O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 21
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 16
- 230000002194 synthesizing effect Effects 0.000 claims description 14
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 12
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 11
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 10
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 9
- 238000006462 rearrangement reaction Methods 0.000 claims description 9
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 8
- 239000003054 catalyst Substances 0.000 claims description 7
- -1 benzyl compound Chemical class 0.000 claims description 6
- 239000007800 oxidant agent Substances 0.000 claims description 6
- 239000001632 sodium acetate Substances 0.000 claims description 6
- 235000017281 sodium acetate Nutrition 0.000 claims description 6
- OEBXWWBYZJNKRK-UHFFFAOYSA-N 1-methyl-2,3,4,6,7,8-hexahydropyrimido[1,2-a]pyrimidine Chemical compound C1CCN=C2N(C)CCCN21 OEBXWWBYZJNKRK-UHFFFAOYSA-N 0.000 claims description 5
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 claims description 5
- 229940073608 benzyl chloride Drugs 0.000 claims description 5
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims description 5
- GDOPTJXRTPNYNR-UHFFFAOYSA-N methyl-cyclopentane Natural products CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 claims description 5
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 claims description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 claims description 4
- 235000011056 potassium acetate Nutrition 0.000 claims description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 4
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 claims description 4
- 229960002218 sodium chlorite Drugs 0.000 claims description 4
- 239000003810 Jones reagent Substances 0.000 claims description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- 229930040373 Paraformaldehyde Natural products 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- NKLCNNUWBJBICK-UHFFFAOYSA-N dess–martin periodinane Chemical compound C1=CC=C2I(OC(=O)C)(OC(C)=O)(OC(C)=O)OC(=O)C2=C1 NKLCNNUWBJBICK-UHFFFAOYSA-N 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 229920002866 paraformaldehyde Polymers 0.000 claims description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 2
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical group [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 claims 2
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 239000011388 polymer cement concrete Substances 0.000 claims 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 claims 1
- 229910001948 sodium oxide Inorganic materials 0.000 claims 1
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical compound OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 abstract description 22
- 238000007254 oxidation reaction Methods 0.000 abstract description 4
- 239000002253 acid Substances 0.000 abstract description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract description 3
- 230000003647 oxidation Effects 0.000 abstract description 3
- 230000008707 rearrangement Effects 0.000 abstract description 3
- 239000007858 starting material Substances 0.000 abstract description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 54
- 238000006243 chemical reaction Methods 0.000 description 40
- VEYIMQVTPXPUHA-UHFFFAOYSA-N 3-hydroxypyran-4-one Chemical compound OC1=COC=CC1=O VEYIMQVTPXPUHA-UHFFFAOYSA-N 0.000 description 25
- MOHHRUXIPJXZBS-UHFFFAOYSA-N 3-hydroxy-2-(hydroxymethyl)pyran-4-one Chemical compound OCC=1OC=CC(=O)C=1O MOHHRUXIPJXZBS-UHFFFAOYSA-N 0.000 description 24
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 24
- 238000003756 stirring Methods 0.000 description 18
- 238000003786 synthesis reaction Methods 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 230000015572 biosynthetic process Effects 0.000 description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 16
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 16
- 239000012074 organic phase Substances 0.000 description 14
- XOBCNTRYSGLSBO-UHFFFAOYSA-N 2-(hydroxymethyl)-3-phenylmethoxypyran-4-one Chemical compound O1C=CC(=O)C(OCC=2C=CC=CC=2)=C1CO XOBCNTRYSGLSBO-UHFFFAOYSA-N 0.000 description 13
- 239000008346 aqueous phase Substances 0.000 description 10
- 239000012043 crude product Substances 0.000 description 8
- 239000012141 concentrate Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000002994 raw material Substances 0.000 description 5
- AKKLAJYCGVIWBS-UHFFFAOYSA-N O=[N].CC1(C)CCCC(C)(C)N1 Chemical compound O=[N].CC1(C)CCCC(C)(C)N1 AKKLAJYCGVIWBS-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- 239000012452 mother liquor Substances 0.000 description 4
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 4
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 4
- 235000019345 sodium thiosulphate Nutrition 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 3
- FIDLLEYNNRGVFR-CTNGQTDRSA-N (3R)-2-[(11S)-7,8-difluoro-6,11-dihydrobenzo[c][1]benzothiepin-11-yl]-11-hydroxy-5-oxa-1,2,8-triazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-9,12-dione Chemical compound OC1=C2N(C=CC1=O)N([C@@H]1COCCN1C2=O)[C@@H]1C2=C(SCC3=C1C=CC(F)=C3F)C=CC=C2 FIDLLEYNNRGVFR-CTNGQTDRSA-N 0.000 description 2
- 239000005708 Sodium hypochlorite Substances 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000013341 scale-up Methods 0.000 description 2
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- VSTXCZGEEVFJES-UHFFFAOYSA-N 1-cycloundecyl-1,5-diazacycloundec-5-ene Chemical compound C1CCCCCC(CCCC1)N1CCCCCC=NCCC1 VSTXCZGEEVFJES-UHFFFAOYSA-N 0.000 description 1
- 238000006646 Dess-Martin oxidation reaction Methods 0.000 description 1
- JBIHUDRUDVZFPT-UHFFFAOYSA-N O=CC(OC=CC1=O)=C1OCc1ccccc1 Chemical compound O=CC(OC=CC1=O)=C1OCc1ccccc1 JBIHUDRUDVZFPT-UHFFFAOYSA-N 0.000 description 1
- QMBFPWDEXPFSIH-UHFFFAOYSA-N OC(C([O]=C=CC1=O)=C1OCc1ccccc1)=O Chemical compound OC(C([O]=C=CC1=O)=C1OCc1ccccc1)=O QMBFPWDEXPFSIH-UHFFFAOYSA-N 0.000 description 1
- JWIPGAFCGUDKEY-UHFFFAOYSA-L O[Cr](Cl)(=O)=O.C1=CC=NC=C1 Chemical compound O[Cr](Cl)(=O)=O.C1=CC=NC=C1 JWIPGAFCGUDKEY-UHFFFAOYSA-L 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- DIBHLCJAJIKHGB-UHFFFAOYSA-N dec-5-ene Chemical compound [CH2]CCCC=CCCCC DIBHLCJAJIKHGB-UHFFFAOYSA-N 0.000 description 1
- RHWKPHLQXYSBKR-BMIGLBTASA-N dolutegravir Chemical compound C([C@@H]1OCC[C@H](N1C(=O)C1=C(O)C2=O)C)N1C=C2C(=O)NCC1=CC=C(F)C=C1F RHWKPHLQXYSBKR-BMIGLBTASA-N 0.000 description 1
- 229960002542 dolutegravir Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- FIYYMXYOBLWYQO-UHFFFAOYSA-N ortho-iodylbenzoic acid Chemical compound OC(=O)C1=CC=CC=C1I(=O)=O FIYYMXYOBLWYQO-UHFFFAOYSA-N 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000006049 ring expansion reaction Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
- C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
Definitions
- the present invention relates to the field of organic chemical synthesis, and more specifically, to a method of synthesizing 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid.
- this structure sheet has two main synthetic routes, as shown in the figure below.
- the main drawback of this route is that the materials are expensive, the steps are long, and it is difficult to scale up safely:
- Another synthetic method is the following synthetic route. This synthetic route is relatively superior, but selenium dioxide is highly toxic and the amount used is large.
- the invention provides a method for synthesizing 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid.
- a method for synthesizing 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid characterized in that the synthetic route is:
- compound I is Compound II is Compound III is Compound IV is Compound VI is
- the solvent is selected from methanol, isopropanol, tetrahydrofuran, 1,4-dioxane or ethanol, preferably methanol.
- the weak base salt catalyst is selected from sodium acetate or potassium acetate, preferably sodium acetate.
- step S1 the molar ratio of the compound I to chlorine gas is 1:1-2; wherein, when chlorine gas is introduced, the system temperature is controlled at -10°C-25°C, preferably -5°C-5°C.
- the temperature of the rearrangement reaction is controlled at 50°C-80°C, preferably 60°C-70°C.
- the rearrangement reaction is used in step S1, and the yield is high, which can reach more than 50%, which facilitates the subsequent reaction, so that the subsequent reaction only needs four steps of addition, hydroxyl protection, and oxidation to prepare the target product.
- the strong base is selected from sodium hydroxide, sodium methoxide or sodium ethoxide, preferably sodium hydroxide.
- the aldehyde is selected from formaldehyde or paraformaldehyde, preferably formaldehyde.
- the base is selected from sodium hydroxide, sodium methoxide, 1,8-diazabicycloundec-7-ene (DBU), 1,5,7-triazabicarbonate Cyclo[4.4.0]dec-5-ene (TBD), 7-methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene (MTBD), potassium tert-butoxide, Sodium ethoxide or potassium carbonate is preferably sodium hydroxide.
- DBU 1,8-diazabicycloundec-7-ene
- TBD 1,8-diazabicycloundec-7-ene
- MTBD 7-methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene
- Sodium ethoxide or potassium carbonate is preferably sodium hydroxide.
- the benzyl compound is selected from benzyl bromide or benzyl chloride, preferably benzyl chloride.
- the oxidizing agent is selected from the group consisting of manganese dioxide, dimethyl sulfoxide, (1,1,1-triacetoxy)-1,1-dihydro-1,2-phenyliodide -3(1H)-one (Dess-Martin oxidant), 2,2,6,6-tetramethylpiperidine-nitrogen-oxide (TEMPO), o-iodylbenzoic acid (IBX), pyridine chlorochromate (PCC), Jones reagent (JONE'S reagent), sodium chlorite or oxygen, preferably 2,2,6,6-tetramethylpiperidine-nitrogen oxide (TEMPO).
- TEMPO 2,2,6,6-tetramethylpiperidine-nitrogen oxide
- the present invention has the following advantages:
- the technical scheme of the present invention has a novel synthetic route, taking furfuryl alcohol as the starting material, after four steps of rearrangement, addition, hydroxyl protection, and oxidation, the whole preparation process is simple, the steps are few, the raw materials are cheap and easily available, and the use or production is avoided.
- the total molar yield of toxic products and by-products is greater than 32%. It has the characteristics of relatively mild reaction conditions and significantly improves the yield of 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid Rate and purity, at the same time, the conditions of the present invention are controllable, the process is stable, the repeatability is strong, and industrial mass production can be achieved.
- the synthetic route of the technical solution of the present invention does not use expensive raw materials, which greatly reduces the production cost, and the product does not contain heavy metal elements that cause serious pollution to the environment, making it more in line with environmental protection standards.
- the invention discloses a method for synthesizing 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid.
- the synthetic route is:
- compound I is Compound II is Compound III is Compound IV is Intermediate V is Compound VI is
- Tetrahydrofuran (30L), water (20L) and potassium acetate (10kg) were added to the reaction kettle and the temperature was lowered to 5°C.
- Furfuryl alcohol (Compound I) (20kg) was dissolved in tetrahydrofuran (20L) and water (10L), added dropwise to the reaction kettle at a temperature control of 5°C, and chlorine gas (30kg) was introduced into the reaction kettle while dropping. Incubate for 1h, the reaction is over, incubate overnight and filter. The mother liquor was heated to 60°C, stirred for 2h, and cooled to room temperature. filter.
- Tetrahydrofuran (50L), water (20L) and potassium acetate (10kg) were added to the reaction kettle and the temperature was lowered to 5°C.
- Furfuryl alcohol (Compound I) 25 kg was dissolved in tetrahydrofuran (20 L) and water (10 L), added dropwise to the reaction kettle at a temperature control of 5° C., and chlorine gas (36.5 kg) was added to the reaction kettle while dropping. Incubate for 1h, the reaction is over, incubate overnight and filter. The mother liquor was heated to 80°C, stirred for 2h, and cooled to room temperature. filter.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Disclosed is a synthesis method for 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid. The acid takes furfuryl alcohol as a starting material and is prepared with four steps: rearrangement, addition, hydroxyl protection and oxidation.
Description
本发明涉及有机化学合成领域,更具体地,涉及一种3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸的合成方法。The present invention relates to the field of organic chemical synthesis, and more specifically, to a method of synthesizing 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid.
有多种临床前、临床期和上市新药含有3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸片段。如下图所示几种类型药物分子,以及已上市药物如度鲁特韦(GSK1349572)、巴洛沙韦(Baloxavir)含有该重要结构片段。There are a variety of preclinical, clinical, and marketed new drugs that contain 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid fragments. As shown in the figure below, several types of drug molecules, as well as the marketed drugs such as dulutevir (GSK1349572) and baloxavir (Baloxavir) contain this important structural fragment.
目前这一结构片有两条主要的合成路线,合成路线如下图所示。这一路线的主要缺陷是物料很昂贵,步骤长,也难以进行安全地生产放大:At present, this structure sheet has two main synthetic routes, as shown in the figure below. The main drawback of this route is that the materials are expensive, the steps are long, and it is difficult to scale up safely:
另一合成方法为如下合成路线。这一合成路线相对较优,但二氧化硒剧毒且用量大。Another synthetic method is the following synthetic route. This synthetic route is relatively superior, but selenium dioxide is highly toxic and the amount used is large.
然而,这两条路线合成目标结构片段时,发现收率都很低,重复性差。However, when these two routes were used to synthesize the target structure fragments, it was found that the yield was very low and the repeatability was poor.
综上所述,制药行业的发展需要3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸这一类医药中间体,然而其工艺路线存在反应条件苛刻、物料安全性低、难以生产放大的问题。In summary, the development of the pharmaceutical industry requires 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid as a pharmaceutical intermediate. However, its process route has harsh reaction conditions and material safety The problem is low, and it is difficult to produce amplification.
发明内容Summary of the invention
针对现有技术的不足,为改善3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸合成工艺路线反应条件苛刻、工艺安全性低、难以生产放大等缺点,本发明提供了一种3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸的合成方法。In view of the shortcomings of the existing technology, in order to improve the shortcomings of the reaction route of 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid synthesis process, the process safety is low, the production scale is difficult to scale up The invention provides a method for synthesizing 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid.
本发明是通过以下技术方案进行实现的:The present invention is achieved through the following technical solutions:
一种3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸的合成方法,其特征在于,合成路线为:A method for synthesizing 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid, characterized in that the synthetic route is:
进一步的,包括以下步骤,Further, it includes the following steps,
S1、在溶剂和弱碱盐催化剂存在下,化合物I和氯气经重排反应得到化合物II;S1, in the presence of a solvent and a weak base salt catalyst, Compound I and chlorine gas undergo rearrangement reaction to obtain Compound II;
S2、在溶剂和强碱存在下,化合物II和醛经加成反应得到化合物III;S2. In the presence of a solvent and a strong base, compound III and aldehyde are added to give compound III;
S3、在溶剂和碱存在下,化合物III和苄基化合物反应得到化合物IV;S3. In the presence of a solvent and a base, compound III is reacted with a benzyl compound to obtain compound IV;
S4、化合物IV和氧化剂经氧化反应得到化合物VI;S4, compound IV and oxidizing agent are oxidized to obtain compound VI;
其中,化合物I为
化合物II为
化合物III为
化合物IV为
化合物VI 为
Among them, compound I is Compound II is Compound III is Compound IV is Compound VI is
进一步的,步骤S1-S3中,所述溶剂选自包括甲醇、异丙醇、四氢呋喃、1,4-二氧六环或乙醇,优选为甲醇。Further, in steps S1-S3, the solvent is selected from methanol, isopropanol, tetrahydrofuran, 1,4-dioxane or ethanol, preferably methanol.
进一步的,步骤S1中,所述弱碱盐催化剂选自包括乙酸钠或乙酸钾,优选为乙酸钠。Further, in step S1, the weak base salt catalyst is selected from sodium acetate or potassium acetate, preferably sodium acetate.
进一步的,步骤S1中,所述化合物I和氯气的摩尔比为1:1-2;其中,通入氯气时体系温度控制在-10℃-25℃,优选为-5℃-5℃。Further, in step S1, the molar ratio of the compound I to chlorine gas is 1:1-2; wherein, when chlorine gas is introduced, the system temperature is controlled at -10°C-25°C, preferably -5°C-5°C.
所述重排反应的温度控制在50℃-80℃,优选为60℃-70℃。The temperature of the rearrangement reaction is controlled at 50°C-80°C, preferably 60°C-70°C.
在本发明中,步骤S1中采用重排反应,收率高,可达到50%以上,为后续反应提供便利,使得后续反应仅需加成、羟基保护、氧化四步反应就可以制备目标产物。In the present invention, the rearrangement reaction is used in step S1, and the yield is high, which can reach more than 50%, which facilitates the subsequent reaction, so that the subsequent reaction only needs four steps of addition, hydroxyl protection, and oxidation to prepare the target product.
进一步的,步骤S2中,所述强碱选自包括氢氧化钠、甲醇钠或乙醇钠,优选为氢氧化钠。Further, in step S2, the strong base is selected from sodium hydroxide, sodium methoxide or sodium ethoxide, preferably sodium hydroxide.
进一步的,步骤S2中,所述醛选自包括甲醛或多聚甲醛,优选为甲醛。Further, in step S2, the aldehyde is selected from formaldehyde or paraformaldehyde, preferably formaldehyde.
进一步的,步骤S3中,所述碱选自包括氢氧化钠、甲醇钠、1,8-二氮杂二环十一碳-7-烯(DBU)、1,5,7-三氮杂二环[4.4.0]癸-5-烯(TBD)、7-甲基-1,5,7-三氮杂二环[4.4.0]癸-5-烯(MTBD)、叔丁醇钾、乙醇钠或碳酸钾,优选为氢氧化钠。Further, in step S3, the base is selected from sodium hydroxide, sodium methoxide, 1,8-diazabicycloundec-7-ene (DBU), 1,5,7-triazabicarbonate Cyclo[4.4.0]dec-5-ene (TBD), 7-methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene (MTBD), potassium tert-butoxide, Sodium ethoxide or potassium carbonate is preferably sodium hydroxide.
进一步的,步骤S3中,所述苄基化合物选自包括溴化苄或氯化苄,优选为氯化苄。Further, in step S3, the benzyl compound is selected from benzyl bromide or benzyl chloride, preferably benzyl chloride.
进一步的,步骤S4中,所述氧化剂选自包括二氧化锰、二甲基亚砜、(1,1,1- 三乙酰氧基)-1,1-二氢-1,2-苯碘酰-3(1H)-酮(Dess-Martin氧化剂)、2,2,6,6-四甲基哌啶-氮-氧化物(TEMPO)、邻-碘酰基苯甲酸(IBX)、氯铬酸吡啶(PCC)、琼斯试剂(JONE'S试剂)、亚氯酸钠或氧气,优选为2,2,6,6-四甲基哌啶-氮-氧化物(TEMPO)。Further, in step S4, the oxidizing agent is selected from the group consisting of manganese dioxide, dimethyl sulfoxide, (1,1,1-triacetoxy)-1,1-dihydro-1,2-phenyliodide -3(1H)-one (Dess-Martin oxidant), 2,2,6,6-tetramethylpiperidine-nitrogen-oxide (TEMPO), o-iodylbenzoic acid (IBX), pyridine chlorochromate (PCC), Jones reagent (JONE'S reagent), sodium chlorite or oxygen, preferably 2,2,6,6-tetramethylpiperidine-nitrogen oxide (TEMPO).
与现有技术相比,本发明具有如下优点:Compared with the prior art, the present invention has the following advantages:
1、在本发明提供的方法合成3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸,其原料为糠醇,在有乙酸钠或乙酸钾存在下,用氯气氧化发生扩环重排,且重排反应采用常见的弱碱盐催化剂,简单易得,催化剂成本较低,并严格控制重排反应的条件,比如,通入氯气时体系温度以及重排反应的温度。1. Synthesize 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid in the method provided by the present invention. Its raw material is furfuryl alcohol, which is oxidized with chlorine gas in the presence of sodium acetate or potassium acetate Ring expansion rearrangement occurs, and the rearrangement reaction uses a common weak base salt catalyst, which is simple and easy to obtain, the catalyst cost is low, and the conditions of the rearrangement reaction are strictly controlled, such as the system temperature and the temperature of the rearrangement reaction when chlorine gas is introduced .
2、本发明技术方案合成路线新颖,以糠醇为起始原料,经过重排、加成、羟基保护、氧化四步反应,整个制备过程简单,步骤少,原料廉价易得,避免使用或产生剧毒性产物及副产物,总摩尔收率大于32%,具有反应条件相对温和等特点,显著提高了3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸的收率和纯度,同时本发明条件可控,工艺稳定,重复性强,可工业化大批量生产。2. The technical scheme of the present invention has a novel synthetic route, taking furfuryl alcohol as the starting material, after four steps of rearrangement, addition, hydroxyl protection, and oxidation, the whole preparation process is simple, the steps are few, the raw materials are cheap and easily available, and the use or production is avoided. The total molar yield of toxic products and by-products is greater than 32%. It has the characteristics of relatively mild reaction conditions and significantly improves the yield of 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid Rate and purity, at the same time, the conditions of the present invention are controllable, the process is stable, the repeatability is strong, and industrial mass production can be achieved.
3、本发明技术方案的合成路线不使用昂贵的原料,大大降低了生产成本,且产物中不含对环境造成严重污染的重金属元素,使得更加符合环保的标准。3. The synthetic route of the technical solution of the present invention does not use expensive raw materials, which greatly reduces the production cost, and the product does not contain heavy metal elements that cause serious pollution to the environment, making it more in line with environmental protection standards.
本发明公开一种3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸的合成方法,合成路线为:The invention discloses a method for synthesizing 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid. The synthetic route is:
包括以下步骤,It includes the following steps,
S1、在溶剂和弱碱盐催化剂存在下,化合物I和氯气经重排反应得到化合物II;S1, in the presence of a solvent and a weak base salt catalyst, Compound I and chlorine gas undergo rearrangement reaction to obtain Compound II;
S2、在溶剂和强碱存在下,化合物II和醛经加成反应得到化合物III;S2. In the presence of a solvent and a strong base, compound III and aldehyde are added to give compound III;
S3、在溶剂和碱存在下,化合物III和苄基化合物反应得到化合物IV;S3. In the presence of a solvent and a base, compound III is reacted with a benzyl compound to obtain compound IV;
S4、化合物IV和氧化剂经氧化反应生成中间体V,进而得到化合物VI;S4, the compound IV and the oxidant undergo an oxidation reaction to form an intermediate V, and then a compound VI is obtained;
其中,化合物I为
化合物II为
化合物III为
化合物IV为
中间体V为
化合物VI为
Among them, compound I is Compound II is Compound III is Compound IV is Intermediate V is Compound VI is
下面对本发明的较佳实施例进行详细阐述,以使本发明的优点和特征更易被本领域技术人员理解,从而对本发明的保护范围作出更为清楚的界定。The following describes the preferred embodiments of the present invention in detail so that the advantages and features of the present invention can be more easily understood by those skilled in the art, so as to make the protection scope of the present invention more clearly defined.
实施例1Example 1
1、3-羟基-4H-吡喃-4-酮(化合物II)的合成1. Synthesis of 3-hydroxy-4H-pyran-4-one (Compound II)
反应釜中加入甲醇(60L)、水(40L)和乙酸钠(20Kg),降温到-5℃。将糠醇(化合物I)(40kg)溶于甲醇(40L)和水(20L),在控温-5℃滴加反应釜中,边滴加,边向反应釜中通入氯气(57.8kg)。保温1h,反应结束,保温静置过夜,过滤。母液升温50℃,搅拌2h,冷却至室温。过滤。减压浓缩除去甲醇,结晶,得到3-羟基-4H-吡喃-4-酮(化合物II)26.7kg,纯度95%,收率59%。LC-MS:[M+H]
+=113.02。
Methanol (60L), water (40L) and sodium acetate (20Kg) were added to the reaction kettle, and the temperature was lowered to -5°C. Furfuryl alcohol (Compound I) (40 kg) was dissolved in methanol (40 L) and water (20 L), added dropwise to the reaction kettle at a temperature control of -5°C, and chlorine gas (57.8 kg) was introduced into the reaction kettle while dropping. Incubate for 1h, the reaction is over, incubate overnight and filter. The mother liquor was heated to 50°C, stirred for 2h, and cooled to room temperature. filter. It was concentrated under reduced pressure to remove methanol and crystallized to obtain 26.7 kg of 3-hydroxy-4H-pyran-4-one (Compound II) with a purity of 95% and a yield of 59%. LC-MS: [M+H] + = 113.02.
2、3-羟基-2-(羟基甲基)-4H-吡喃-4-酮(化合物III)合成2. Synthesis of 3-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one (compound III)
将3-羟基-4H-吡喃-4-酮(化合物II)(26.7kg)和甲醇(134L)加入到反应釜中搅拌。降温到10℃,滴加氢氧化钠(11.1Kg)和水(38L)的混合溶液。搅拌1h后,滴 加37%甲醛(48L)。升温至室温搅拌24h,反应结束,降温至10℃,用浓盐酸调节pH=1,减压浓缩除去甲醇,加入二氯甲烷(116L)搅拌。然后过滤无机盐,分液。水相再用二氯甲烷(87L)萃取两次。合并有机相减压浓缩,异丙醇套蒸析出固体,降温过滤,得到3-羟基-2-(羟基甲基)-4H-吡喃-4-酮(化合物III)29.1Kg,纯度97%,收率86%。LC-MS:[M+H]
+=143.03。
3-Hydroxy-4H-pyran-4-one (Compound II) (26.7 kg) and methanol (134 L) were added to the reaction kettle and stirred. The temperature was lowered to 10°C, and a mixed solution of sodium hydroxide (11.1Kg) and water (38L) was added dropwise. After stirring for 1h, 37% formaldehyde (48L) was added dropwise. The temperature was raised to room temperature and stirred for 24 h. The reaction was completed, the temperature was lowered to 10° C., the pH was adjusted to 1 with concentrated hydrochloric acid, the methanol was concentrated under reduced pressure, and dichloromethane (116 L) was added and stirred. Then, the inorganic salts are filtered and separated. The aqueous phase was extracted twice more with dichloromethane (87L). The organic phases were combined and concentrated under reduced pressure. The solid was distilled out of the isopropanol jacket and filtered under reduced temperature to obtain 3-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one (Compound III) 29.1Kg with a purity of 97%. The yield was 86%. LC-MS: [M+H] + = 143.03.
3、2-(羟甲基)-3-(苄氧基)-4H-吡喃-4-酮(化合物IV)合成3. Synthesis of 2-(hydroxymethyl)-3-(benzyloxy)-4H-pyran-4-one (Compound IV)
向反应釜中加入3-羟基-2-(羟基甲基)-4H-吡喃-4-酮(化合物III)(29.1Kg)、甲醇(148L)、水(55L)和氢氧化钠(9.8Kg),开启搅拌,升温到70℃。滴加氯化苄(28.6Kg,1.1eq.),70℃保温3.0h。反应结束,降温至室温,过滤,浓缩甲醇。水相用二氯甲烷(60L)萃取三次,合并有机相,减压浓缩,降温过滤,得到2-(羟甲基)-3-(苄氧基)-4H-吡喃-4-酮(化合物IV)39.8Kg,纯度98%,收率84%。LC-MS:[M+H]
+=233.08。
Add 3-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one (Compound III) (29.1Kg), methanol (148L), water (55L) and sodium hydroxide (9.8Kg) to the reaction kettle ), start stirring, and raise the temperature to 70 ℃. Benzyl chloride (28.6Kg, 1.1eq.) was added dropwise and kept at 70℃ for 3.0h. After the reaction, the temperature was lowered to room temperature, filtered, and methanol was concentrated. The aqueous phase was extracted three times with dichloromethane (60 L), the organic phases were combined, concentrated under reduced pressure, and filtered under reduced temperature to obtain 2-(hydroxymethyl)-3-(benzyloxy)-4H-pyran-4-one (compound IV) 39.8Kg, purity 98%, yield 84%. LC-MS: [M+H] + = 233.08.
4、3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸(化合物VI)合成4. Synthesis of 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid (Compound VI)
向反应釜中加入2-(羟甲基)-3-(苄氧基)-4H-吡喃-4-酮(化合物IV)39.8Kg、二氯甲烷(340L)和水(170L)开启搅拌。然后在加入碳酸氢钠(77Kg)、溴化钠(1.6Kg)和2,2,6,6-四甲基哌啶-氮-氧化物(TEMPO)(2.3Kg),降温到5℃,滴加10%次氯酸钠(340Kg),滴加完毕在5℃搅拌1h,反应结束。加入30%硫代硫 酸钠水溶液(242L),搅拌1h。加浓盐酸调节pH=4,分离有机相,水相用二氯甲烷(120L)萃取两次,合并有机相,减压浓缩得到粗品。粗品用乙腈重结晶,得到3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸(化合物VI)32.4Kg,纯度99%,收率77%。LC-MS:[M+H]
+=247.06,[M]
+=245.05;
1H NMR(DMSO-d
6)δ8.00(d,J=5.6Hz,1H),7.17(s,5H),6.34(d,J=5.7Hz,1H),4.91(s,2H),2.30(s,1H)。
Add 2-(hydroxymethyl)-3-(benzyloxy)-4H-pyran-4-one (Compound IV) 39.8Kg, dichloromethane (340L) and water (170L) to the reaction kettle to start stirring. Then add sodium bicarbonate (77Kg), sodium bromide (1.6Kg) and 2,2,6,6-tetramethylpiperidine-nitrogen-oxide (TEMPO) (2.3Kg), cool to 5℃, drop Add 10% sodium hypochlorite (340Kg). After the dropwise addition, stir at 5°C for 1 hour. The reaction is completed. Add 30% aqueous sodium thiosulfate solution (242L) and stir for 1 h. Add concentrated hydrochloric acid to adjust pH=4, separate the organic phase, extract the aqueous phase twice with dichloromethane (120L), combine the organic phases, and concentrate under reduced pressure to obtain the crude product. The crude product was recrystallized from acetonitrile to obtain 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid (Compound VI) 32.4Kg, purity 99%, yield 77%. LC-MS: [M+H] + = 247.06, [M] + = 245.05; 1 H NMR (DMSO-d 6 ) δ8.00 (d, J = 5.6 Hz, 1H), 7.17 (s, 5H), 6.34 (d, J = 5.7 Hz, 1H), 4.91 (s, 2H), 2.30 (s, 1H).
实施例2Example 2
1、3-羟基-4H-吡喃-4-酮(化合物II)的合成1. Synthesis of 3-hydroxy-4H-pyran-4-one (Compound II)
反应釜中加入乙醇(30L)、水(20L)和乙酸钠(10Kg),降温到5℃。将糠醇(化合物I)(20kg)溶于乙醇(20L)和水(10L),在控温5℃滴加反应釜中,边滴加,边向反应釜中通入氯气(25.5kg)。保温1h,反应结束,保温静置过夜,过滤。母液升温70℃,搅拌2h,冷却至室温。过滤。减压浓缩除去乙醇,结晶,得到3-羟基-4H-吡喃-4-酮(化合物II)14.2kg,纯度94%,收率62%。LC-MS:[M+H]
+=113.02。
Ethanol (30L), water (20L) and sodium acetate (10Kg) were added to the reaction kettle, and the temperature was lowered to 5°C. Furfuryl alcohol (Compound I) (20 kg) was dissolved in ethanol (20 L) and water (10 L), added dropwise to the reaction kettle at a temperature control of 5°C, and chlorine gas (25.5 kg) was introduced into the reaction kettle while dropping. Incubate for 1h, the reaction is over, incubate overnight and filter. The mother liquor was heated to 70°C, stirred for 2h, and cooled to room temperature. filter. Concentrate under reduced pressure to remove ethanol and crystallize to obtain 14.2 kg of 3-hydroxy-4H-pyran-4-one (Compound II) with a purity of 94% and a yield of 62%. LC-MS: [M+H] + = 113.02.
2、3-羟基-2-(羟基甲基)-4H-吡喃-4-酮(化合物III)合成2. Synthesis of 3-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one (compound III)
将3-羟基-4H-吡喃-4-酮(化合物II)(14.2kg)和甲醇(70L)加入到反应釜中搅拌。降温到5℃,滴加氢氧化钠(5.6Kg)和水(18L)的混合溶液。搅拌1h后,滴加 37%甲醛(25L)。升温至室温搅拌24h,反应结束,降温至5℃,用浓盐酸调节pH=1,减压浓缩除去甲醇,加入二氯甲烷(56L)搅拌。然后过滤无机盐,分液。水相再用二氯甲烷(45L)萃取两次。合并有机相减压浓缩,异丙醇套蒸析出固体,降温过滤,得到3-羟基-2-(羟基甲基)-4H-吡喃-4-酮(化合物III)15.5Kg,纯度96%,收率86%。LC-MS:[M+H]
+=143.03。
3-Hydroxy-4H-pyran-4-one (Compound II) (14.2 kg) and methanol (70 L) were added to the reactor and stirred. The temperature was lowered to 5°C, and a mixed solution of sodium hydroxide (5.6Kg) and water (18L) was added dropwise. After stirring for 1h, 37% formaldehyde (25L) was added dropwise. The temperature was raised to room temperature and stirred for 24 h. The reaction was completed, the temperature was lowered to 5° C., the pH was adjusted to 1 with concentrated hydrochloric acid, the methanol was concentrated under reduced pressure, and dichloromethane (56 L) was added to stir. Then, the inorganic salts are filtered and separated. The aqueous phase was extracted twice more with dichloromethane (45L). The organic phases were combined and concentrated under reduced pressure. The solid was distilled out of the isopropanol jacket, and the temperature was filtered to obtain 3-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one (Compound III) 15.5 Kg, purity 96%. The yield was 86%. LC-MS: [M+H] + = 143.03.
3、2-(羟甲基)-3-(苄氧基)-4H-吡喃-4-酮(化合物IV)合成3. Synthesis of 2-(hydroxymethyl)-3-(benzyloxy)-4H-pyran-4-one (Compound IV)
向反应釜中加入3-羟基-2-(羟基甲基)-4H-吡喃-4-酮(化合物III)(15.5Kg)、甲醇(65L)、水(28L)和氢氧化钠(4.8Kg),开启搅拌,升温到70℃。滴加氯化苄(28.6Kg,1.1eq.),70℃保温3.0h。反应结束,降温至室温,过滤,浓缩甲醇。水相用二氯甲烷(35L)萃取三次,合并有机相,减压浓缩,降温过滤,得到2-(羟甲基)-3-(苄氧基)-4H-吡喃-4-酮(化合物IV)19.8Kg,纯度96%,收率78%。LC-MS:[M+H]
+=233.08。
Add 3-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one (Compound III) (15.5Kg), methanol (65L), water (28L) and sodium hydroxide (4.8Kg) to the reaction kettle ), start stirring, and raise the temperature to 70 ℃. Benzyl chloride (28.6Kg, 1.1eq.) was added dropwise and kept at 70℃ for 3.0h. After the reaction, the temperature was lowered to room temperature, filtered, and methanol was concentrated. The aqueous phase was extracted three times with dichloromethane (35L), the organic phases were combined, concentrated under reduced pressure, and filtered under reduced temperature to obtain 2-(hydroxymethyl)-3-(benzyloxy)-4H-pyran-4-one (compound IV) 19.8Kg, purity 96%, yield 78%. LC-MS: [M+H] + = 233.08.
4、3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸(化合物VI)合成4. Synthesis of 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid (Compound VI)
向反应釜中加入2-(羟甲基)-3-(苄氧基)-4H-吡喃-4-酮(化合物IV)19.8Kg、二氯甲烷(176L)和水(85L)开启搅拌。然后在加入碳酸氢钠(46Kg)、溴化钠(0.9Kg)和2,2,6,6-四甲基哌啶-氮-氧化物(TEMPO)(1.4Kg),降温到5℃,滴加10%次氯酸钠(175Kg),滴加完毕在5℃搅拌1h,反应结束。加入30%硫代硫酸钠水 溶液(119L),搅拌1h。加浓盐酸调节pH=3.5,分离有机相,水相用二氯甲烷(65L)萃取两次,合并有机相,减压浓缩得到粗品。粗品用乙腈重结晶,得到3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸(化合物VI)17.5Kg,纯度99%,收率83%。LC-MS:[M+H]
+=247.06,[M]
+=245.05;
1H NMR(DMSO-d
6)δ8.00(d,J=5.6Hz,1H),7.17(s,5H),6.34(d,J=5.7Hz,1H),4.91(s,2H),2.30(s,1H)。
Add 2-(hydroxymethyl)-3-(benzyloxy)-4H-pyran-4-one (Compound IV) 19.8Kg, dichloromethane (176L) and water (85L) to the reaction kettle to start stirring. Then add sodium bicarbonate (46Kg), sodium bromide (0.9Kg) and 2,2,6,6-tetramethylpiperidine-nitrogen-oxide (TEMPO) (1.4Kg), drop the temperature to 5℃, drop Add 10% sodium hypochlorite (175Kg). After the dropwise addition, stir at 5°C for 1 h. The reaction is completed. Add 30% aqueous sodium thiosulfate solution (119L) and stir for 1 h. Add concentrated hydrochloric acid to adjust pH=3.5, separate the organic phase, extract the aqueous phase twice with dichloromethane (65L), combine the organic phases, and concentrate under reduced pressure to obtain the crude product. The crude product was recrystallized from acetonitrile to obtain 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid (Compound VI) 17.5Kg, purity 99%, yield 83%. LC-MS: [M+H] + = 247.06, [M] + = 245.05; 1 H NMR (DMSO-d 6 ) δ8.00 (d, J = 5.6 Hz, 1H), 7.17 (s, 5H), 6.34 (d, J = 5.7 Hz, 1H), 4.91 (s, 2H), 2.30 (s, 1H).
实施例3Example 3
1、3-羟基-4H-吡喃-4-酮(化合物II)合成1. Synthesis of 3-hydroxy-4H-pyran-4-one (Compound II)
反应釜中加入四氢呋喃(30L)、水(20L)和乙酸钾(10kg)降温到5℃。将糠醇(化合物I)(20kg)溶于四氢呋喃(20L)和水(10L),在控温5℃滴加反应釜中,边滴加,边向反应釜中通入氯气(30kg)。保温1h,反应结束,保温静置过夜,过滤。母液升温60℃,搅拌2h,冷却至室温。过滤。减压浓缩除去四氢呋喃,结晶,得到3-羟基-4H-吡喃-4-酮(化合物II)12.4kg,纯度95%,收率54%。LC-MS:[M+H]
+=113.02。
Tetrahydrofuran (30L), water (20L) and potassium acetate (10kg) were added to the reaction kettle and the temperature was lowered to 5°C. Furfuryl alcohol (Compound I) (20kg) was dissolved in tetrahydrofuran (20L) and water (10L), added dropwise to the reaction kettle at a temperature control of 5°C, and chlorine gas (30kg) was introduced into the reaction kettle while dropping. Incubate for 1h, the reaction is over, incubate overnight and filter. The mother liquor was heated to 60°C, stirred for 2h, and cooled to room temperature. filter. Concentrate under reduced pressure to remove tetrahydrofuran and crystallize to obtain 12.4 kg of 3-hydroxy-4H-pyran-4-one (Compound II) with a purity of 95% and a yield of 54%. LC-MS: [M+H] + = 113.02.
2、3-羟基-2-(羟基甲基)-4H-吡喃-4-酮(化合物III)合成2. Synthesis of 3-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one (compound III)
将3-羟基-4H-吡喃-4-酮(化合物II)(12.4kg)和甲醇(76L)加入到反应釜中搅拌。降温到10℃,滴加甲醇钠(7.2Kg)和甲醇(45L)的混合溶液。搅拌1h后,滴 加40%甲醛(22.5L)。升温至室温搅24h,反应结束,降温至10℃,用浓盐酸调节pH=1,减压浓缩除去甲醇,加入二氯甲烷(60L)搅拌。然后过滤无机盐,分液。水相再用二氯甲烷(45L)萃取两次。合并有机相减压浓缩,异丙醇套蒸析出固体,降温过滤,得到3-羟基-2-(羟基甲基)-4H-吡喃-4-酮(化合物III)12.7Kg,纯度96%,收率82%。LC-MS:[M+H]
+=143.03。
3-Hydroxy-4H-pyran-4-one (Compound II) (12.4 kg) and methanol (76 L) were added to the reaction kettle and stirred. The temperature was lowered to 10°C, and a mixed solution of sodium methoxide (7.2Kg) and methanol (45L) was added dropwise. After stirring for 1 h, 40% formaldehyde (22.5 L) was added dropwise. The temperature was raised to room temperature and stirred for 24h, the reaction was completed, the temperature was lowered to 10°C, the pH was adjusted to 1 with concentrated hydrochloric acid, the methanol was concentrated under reduced pressure, and dichloromethane (60L) was added to stir. Then, the inorganic salts are filtered and separated. The aqueous phase was extracted twice more with dichloromethane (45L). The organic phases were combined and concentrated under reduced pressure. The solid was distilled out of the isopropanol jacket and filtered under reduced temperature to obtain 3-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one (Compound III) 12.7 Kg with a purity of 96%. The yield was 82%. LC-MS: [M+H] + = 143.03.
3、2-(羟甲基)-3-(苄氧基)-4H-吡喃-4-酮(化合物IV)合成3. Synthesis of 2-(hydroxymethyl)-3-(benzyloxy)-4H-pyran-4-one (Compound IV)
向反应釜中加入3-羟基-2-(羟基甲基)-4H-吡喃-4-酮(化合物III)(12.7Kg)、甲醇(127L)和碳酸钾(18.5Kg),开启搅拌,升温到70℃。滴加溴化苄(16.8Kg,1.1eq.),70℃保温2.0h。反应结束,降温至室温,过滤,浓缩甲醇。加水(60L)和二氯甲烷(120L),洗涤,分层,水相用二氯甲烷(30L)萃取三次。合并有机相,减压浓缩,降温过滤,得到2-(羟甲基)-3-(苄氧基)-4H-吡喃-4-酮(化合物IV)16.8Kg,纯度98%,收率81%。LC-MS:[M+H]
+=233.08。
Add 3-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one (Compound III) (12.7Kg), methanol (127L) and potassium carbonate (18.5Kg) to the reaction kettle, start stirring and heat up To 70°C. Benzyl bromide (16.8Kg, 1.1eq.) was added dropwise and kept at 70°C for 2.0h. After the reaction, the temperature was lowered to room temperature, filtered, and methanol was concentrated. Water (60 L) and dichloromethane (120 L) were added, washed, and the layers were separated. The aqueous phase was extracted three times with dichloromethane (30 L). The organic phases were combined, concentrated under reduced pressure, and filtered under reduced temperature to obtain 2-(hydroxymethyl)-3-(benzyloxy)-4H-pyran-4-one (Compound IV) 16.8Kg, purity 98%, yield 81 %. LC-MS: [M+H] + = 233.08.
4、3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸(化合物VI)合成4. Synthesis of 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid (Compound VI)
向反应釜中加入2-(羟甲基)-3-(苄氧基)-4H-吡喃-4-酮(化合物IV)(16.8Kg)、乙腈(135L)和邻-碘酰基苯甲酸(IBX)(24.3kg),加热回流6h。TLC监测原料消失,降温至室温,过滤。滤液中加入亚氯酸钠(19.5kg)和水(135L),室温搅拌10h。过滤,滤液中加30%的硫代硫酸钠(113L)搅拌1h, 加浓盐酸调节pH=4,减压浓缩除去乙腈,加入乙酸乙酯(120L)萃取三次。合并有机相,减压浓缩,降温过滤得到粗品。粗品用乙腈重结晶,得到3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸(化合物VI)12.7Kg,纯度99%,收率71.3%。LC-MS:[M+H]
+=247.06,[M]
+=245.05;
1H NMR(DMSO-d
6)δ8.00(d,J=5.6Hz,1H),7.17(s,5H),6.34(d,J=5.7Hz,1H),4.91(s,2H),2.30(s,1H)。
Add 2-(hydroxymethyl)-3-(benzyloxy)-4H-pyran-4-one (Compound IV) (16.8Kg), acetonitrile (135L) and o-iodoylbenzoic acid ( IBX) (24.3kg), heated to reflux for 6h. TLC monitored the disappearance of the raw materials, cooled to room temperature, and filtered. Sodium chlorite (19.5kg) and water (135L) were added to the filtrate and stirred at room temperature for 10h. Filter, add 30% sodium thiosulfate (113L) to the filtrate and stir for 1 h, add concentrated hydrochloric acid to adjust pH=4, concentrate under reduced pressure to remove acetonitrile, add ethyl acetate (120L) for extraction three times. The organic phases were combined, concentrated under reduced pressure, and filtered under reduced temperature to obtain a crude product. The crude product was recrystallized from acetonitrile to obtain 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid (Compound VI) 12.7 Kg, purity 99%, yield 71.3%. LC-MS: [M+H] + = 247.06, [M] + = 245.05; 1 H NMR (DMSO-d 6 ) δ8.00 (d, J = 5.6 Hz, 1H), 7.17 (s, 5H), 6.34 (d, J = 5.7 Hz, 1H), 4.91 (s, 2H), 2.30 (s, 1H).
实施例4Example 4
1、3-羟基-4H-吡喃-4-酮(化合物II)合成1. Synthesis of 3-hydroxy-4H-pyran-4-one (Compound II)
反应釜中加入四氢呋喃(50L)、水(20L)和乙酸钾(10kg)降温到5℃。将糠醇(化合物I)(25kg)溶于四氢呋喃(20L)和水(10L),在控温5℃滴加反应釜中,边滴加,边向反应釜中通入氯气(36.5kg)。保温1h,反应结束,保温静置过夜,过滤。母液升温80℃,搅拌2h,冷却至室温。过滤。减压浓缩除去四氢呋喃,结晶,得到3-羟基-4H-吡喃-4-酮(化合物II)16.5kg,纯度95%,收率58%。LC-MS:[M+H]
+=113.02。
Tetrahydrofuran (50L), water (20L) and potassium acetate (10kg) were added to the reaction kettle and the temperature was lowered to 5°C. Furfuryl alcohol (Compound I) (25 kg) was dissolved in tetrahydrofuran (20 L) and water (10 L), added dropwise to the reaction kettle at a temperature control of 5° C., and chlorine gas (36.5 kg) was added to the reaction kettle while dropping. Incubate for 1h, the reaction is over, incubate overnight and filter. The mother liquor was heated to 80°C, stirred for 2h, and cooled to room temperature. filter. Concentrate under reduced pressure to remove tetrahydrofuran and crystallize to obtain 16.5 kg of 3-hydroxy-4H-pyran-4-one (Compound II) with a purity of 95% and a yield of 58%. LC-MS: [M+H] + = 113.02.
2、3-羟基-2-(羟基甲基)-4H-吡喃-4-酮(化合物III)合成2. Synthesis of 3-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one (compound III)
将3-羟基-4H-吡喃-4-酮(化合物II)(16.5kg)和乙醇(86L)加入到反应釜中搅拌。降温到10℃,滴加乙醇钠(8.4Kg)和乙醇(56L)的混合溶液。搅拌1h后,滴 加40%甲醛(25.5L)。升温至室温搅24h,反应结束,降温至10℃,用浓盐酸调节pH=1,减压浓缩除去乙醇,加入二氯甲烷(75L)搅拌。然后过滤无机盐,分液。水相再用二氯甲烷(50L)萃取两次。合并有机相减压浓缩,异丙醇套蒸析出固体,降温过滤,得到3-羟基-2-(羟基甲基)-4H-吡喃-4-酮(化合物III)15.5Kg,纯度97%,收率74%。LC-MS:[M+H]
+=143.03。
3-Hydroxy-4H-pyran-4-one (Compound II) (16.5 kg) and ethanol (86 L) were added to the reaction kettle and stirred. The temperature was lowered to 10°C, and a mixed solution of sodium ethoxide (8.4Kg) and ethanol (56L) was added dropwise. After stirring for 1 h, 40% formaldehyde (25.5 L) was added dropwise. The temperature was raised to room temperature and stirred for 24h, the reaction was completed, the temperature was lowered to 10°C, the pH was adjusted to 1 with concentrated hydrochloric acid, the ethanol was concentrated under reduced pressure, and dichloromethane (75L) was added and stirred. Then, the inorganic salts are filtered and separated. The aqueous phase was extracted twice more with dichloromethane (50 L). The organic phases were combined and concentrated under reduced pressure. The solid was distilled out of the isopropanol jacket and filtered under reduced temperature to obtain 3-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one (Compound III) 15.5Kg with a purity of 97%. The yield is 74%. LC-MS: [M+H] + = 143.03.
3、2-(羟甲基)-3-(苄氧基)-4H-吡喃-4-酮(化合物IV)合成3. Synthesis of 2-(hydroxymethyl)-3-(benzyloxy)-4H-pyran-4-one (Compound IV)
向反应釜中加入3-羟基-2-(羟基甲基)-4H-吡喃-4-酮(化合物III)(15.5Kg)、甲醇(135L)和碳酸钾(24Kg),开启搅拌,升温到70℃。滴加溴化苄(18.6Kg,1.1eq.),70℃保温2.0h。反应结束,降温至室温,过滤,浓缩甲醇。加水(65L)和二氯甲烷(135L),洗涤,分层,水相用二氯甲烷(35L)萃取三次。合并有机相,减压浓缩,降温过滤,得到2-(羟甲基)-3-(苄氧基)-4H-吡喃-4-酮(化合物IV)19.4Kg,纯度98%,收率76%。LC-MS:[M+H]
+=233.08。
Add 3-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one (Compound III) (15.5Kg), methanol (135L) and potassium carbonate (24Kg) to the reaction kettle, start stirring, and warm up to 70℃. Benzyl bromide (18.6Kg, 1.1eq.) was added dropwise and kept at 70°C for 2.0h. After the reaction, the temperature was lowered to room temperature, filtered, and methanol was concentrated. Water (65L) and dichloromethane (135L) were added, washed, and the layers were separated. The aqueous phase was extracted three times with dichloromethane (35L). The organic phases were combined, concentrated under reduced pressure, and filtered under reduced temperature to obtain 2-(hydroxymethyl)-3-(benzyloxy)-4H-pyran-4-one (Compound IV) 19.4Kg, purity 98%, yield 76 %. LC-MS: [M+H] + = 233.08.
4、3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸(化合物VI)合成4. Synthesis of 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid (Compound VI)
向反应釜中加入2-(羟甲基)-3-(苄氧基)-4H-吡喃-4-酮(化合物IV)(19.4Kg)、乙腈(145L)和邻-碘酰基苯甲酸(IBX)(25.6kg),加热回流6h。TLC监测原料消失,降温至室温,过滤。滤液中加入亚氯酸钠(24.2kg)和水 (145L),室温搅拌10h。过滤,滤液中加30%的硫代硫酸钠(125L)搅拌1h,加浓盐酸调节pH=4,减压浓缩除去乙腈,加入乙酸乙酯(138L)萃取三次。合并有机相,减压浓缩,降温过滤得到粗品。粗品用乙腈重结晶,得到3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸(化合物VI)14.6Kg,纯度99%,收率71%。LC-MS:[M+H]
+=247.06,[M]
+=245.05;
1H NMR(DMSO-d
6)δ8.00(d,J=5.6Hz,1H),7.17(s,5H),6.34(d,J=5.7Hz,1H),4.91(s,2H),2.30(s,1H)。
Add 2-(hydroxymethyl)-3-(benzyloxy)-4H-pyran-4-one (Compound IV) (19.4Kg), acetonitrile (145L) and o-iodoylbenzoic acid ( IBX) (25.6kg), heated to reflux for 6h. TLC monitored the disappearance of the raw materials, cooled to room temperature, and filtered. Sodium chlorite (24.2kg) and water (145L) were added to the filtrate and stirred at room temperature for 10h. Filter, add 30% sodium thiosulfate (125L) to the filtrate and stir for 1 h, add concentrated hydrochloric acid to adjust pH=4, concentrate under reduced pressure to remove acetonitrile, add ethyl acetate (138L) for extraction three times. The organic phases were combined, concentrated under reduced pressure, and filtered under reduced temperature to obtain a crude product. The crude product was recrystallized from acetonitrile to obtain 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid (Compound VI) 14.6 Kg, purity 99%, yield 71%. LC-MS: [M+H] + = 247.06, [M] + = 245.05; 1 H NMR (DMSO-d 6 ) δ8.00 (d, J = 5.6 Hz, 1H), 7.17 (s, 5H), 6.34 (d, J = 5.7 Hz, 1H), 4.91 (s, 2H), 2.30 (s, 1H).
以上仅为本发明的优选实施例,并非因此限制本发明的专利范围,凡是利用本发明说明书所作的等效结构或等效流程变换,或直接或间接运用在其他相关的技术领域,均同理包括在本发明的专利保护范围内。The above are only preferred embodiments of the present invention and do not limit the patent scope of the present invention. Any equivalent structure or equivalent process transformation made by the description of the present invention, or directly or indirectly used in other related technical fields, the same is true Included in the patent protection scope of the present invention.
Claims (10)
- 根据权利要求1所述的一种3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸的合成方法,其特征在于,包括以下步骤,The method for synthesizing 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid according to claim 1, characterized in that it includes the following steps,S1、在溶剂和弱碱盐催化剂存在下,化合物I和氯气经重排反应得到化合物II;S1, in the presence of a solvent and a weak base salt catalyst, Compound I and chlorine gas undergo rearrangement reaction to obtain Compound II;S2、在溶剂和强碱存在下,化合物II和醛经加成反应得到化合物III;S2. In the presence of a solvent and a strong base, compound III and aldehyde are added to give compound III;S3、在溶剂和碱存在下,化合物III和苄基化合物反应得到化合物IV;S3. In the presence of a solvent and a base, compound III is reacted with a benzyl compound to obtain compound IV;S4、化合物IV和氧化剂经氧化反应得到化合物VI;S4, compound IV and oxidizing agent are oxidized to obtain compound VI;
- 根据权利要求2所述的一种3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸的合成方法,其特征在于,步骤S1-S3中,所述溶剂选自包括甲醇、异丙醇、四氢呋喃、1,4-二氧六环或乙醇。The method for synthesizing 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid according to claim 2, wherein in steps S1-S3, the solvent is selected from Including methanol, isopropanol, tetrahydrofuran, 1,4-dioxane or ethanol.
- 根据权利要求2所述的一种3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸的合成方法,其特征在于,步骤S1中,所述弱碱盐催化剂选自包括乙酸钠或乙酸钾。The method for synthesizing 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid according to claim 2, wherein in step S1, the weak base salt catalyst is selected It includes sodium acetate or potassium acetate.
- 根据权利要求2所述的一种3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸的合成方法,其特征在于,步骤S1中,所述化合物I和氯气的摩尔比为1:1-2;所述重排反应的温度控制在50℃-80℃。The method for synthesizing 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid according to claim 2, wherein in step S1, the compound I and chlorine The molar ratio is 1:1-2; the temperature of the rearrangement reaction is controlled at 50°C-80°C.
- 根据权利要求2所述的一种3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸的合成方法,其特征在于,步骤S2中,所述强碱选自包括氢氧化钠、甲醇钠或乙醇钠。The method for synthesizing 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid according to claim 2, wherein in step S2, the strong base is selected from the group consisting of Sodium hydroxide, sodium methoxide or sodium ethoxide.
- 根据权利要求2所述的一种3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸的合成方法,其特征在于,步骤S2中,所述醛选自包括甲醛或多聚甲醛。The method for synthesizing 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid according to claim 2, wherein in step S2, the aldehyde is selected from formaldehyde Or paraformaldehyde.
- 根据权利要求2所述的一种3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸的合成方法,其特征在于:步骤S3中,所述碱选自包括氢氧化钠、甲醇钠、DBU、TBD、MTBD、叔丁醇钾、乙醇钠或碳酸钾。A method for synthesizing 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid according to claim 2, wherein in step S3, the base is selected from hydrogen Sodium oxide, sodium methoxide, DBU, TBD, MTBD, potassium tert-butoxide, sodium ethoxide or potassium carbonate.
- 根据权利要求2所述的一种3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸的合成方法,其特征在于,步骤S3中,所述苄基化合物选自包括溴化苄或氯化苄。The method for synthesizing 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid according to claim 2, wherein in step S3, the benzyl compound is selected from Including benzyl bromide or benzyl chloride.
- 根据权利要求2所述的一种3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸的合成方法,其特征在于,步骤S4中,所述氧化剂选自包括二氧化锰、二甲基亚砜、Dess-Martin试剂、TEMPO、IBX、PCC、JONE'S试剂、亚氯酸钠或氧气。The method for synthesizing 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid according to claim 2, wherein in step S4, the oxidizing agent is selected from Manganese oxide, dimethyl sulfoxide, Dess-Martin reagent, TEMPO, IBX, PCC, JONE'S reagent, sodium chlorite or oxygen.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2018/123144 WO2020132820A1 (en) | 2018-12-24 | 2018-12-24 | Synthesis method for 3-(benzyloxy)-4-oxo-4h-pyran-2-carboxylic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2018/123144 WO2020132820A1 (en) | 2018-12-24 | 2018-12-24 | Synthesis method for 3-(benzyloxy)-4-oxo-4h-pyran-2-carboxylic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2020132820A1 true WO2020132820A1 (en) | 2020-07-02 |
Family
ID=71129323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2018/123144 WO2020132820A1 (en) | 2018-12-24 | 2018-12-24 | Synthesis method for 3-(benzyloxy)-4-oxo-4h-pyran-2-carboxylic acid |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2020132820A1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0281289A1 (en) * | 1987-03-03 | 1988-09-07 | The Upjohn Company | Antibiotic sulfonylaminocarbonyl activated beta-lactams |
WO1998054138A1 (en) * | 1997-05-29 | 1998-12-03 | Btg International Limited | Novel orally active iron (iii) chelators |
CN101513402A (en) * | 2001-08-10 | 2009-08-26 | 盐野义制药株式会社 | Antiviral agent |
CN105481812A (en) * | 2015-11-30 | 2016-04-13 | 重庆天奕恒化科技有限公司 | 5-benzyloxy-4-oxo-4H-pyran-2-carboxylic acid preparation method |
CN107709299A (en) * | 2015-04-24 | 2018-02-16 | 盐野义制药株式会社 | 6 membered heterocycle derivatives and the pharmaceutical composition containing it |
-
2018
- 2018-12-24 WO PCT/CN2018/123144 patent/WO2020132820A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0281289A1 (en) * | 1987-03-03 | 1988-09-07 | The Upjohn Company | Antibiotic sulfonylaminocarbonyl activated beta-lactams |
WO1998054138A1 (en) * | 1997-05-29 | 1998-12-03 | Btg International Limited | Novel orally active iron (iii) chelators |
CN101513402A (en) * | 2001-08-10 | 2009-08-26 | 盐野义制药株式会社 | Antiviral agent |
CN107709299A (en) * | 2015-04-24 | 2018-02-16 | 盐野义制药株式会社 | 6 membered heterocycle derivatives and the pharmaceutical composition containing it |
CN105481812A (en) * | 2015-11-30 | 2016-04-13 | 重庆天奕恒化科技有限公司 | 5-benzyloxy-4-oxo-4H-pyran-2-carboxylic acid preparation method |
Non-Patent Citations (1)
Title |
---|
LI, MING ET AL: "Synthesis of Pyromeconic Acid", CHEMICAL WORLD, no. 12, 31 December 2005 (2005-12-31), pages 749 - 751, XP009521753, DOI: 10.19500/j.cnki.0367-6358.2005.12.015 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109438405B (en) | Synthetic method of 3- (benzyloxy) -4-oxo-4H-pyran-2-carboxylic acid | |
EP0300614B1 (en) | Process for the preparation of substituted indolinone derivatives | |
KR20100017101A (en) | Process for the preparation of gefitinib | |
CN113956312A (en) | Preparation method of mopilavir | |
CN114805314A (en) | Synthesis method of Ensaitevir | |
CN112079848A (en) | Synthesis method of baroxavir key intermediate | |
CN104402909B (en) | A kind of synthetic method of cefoxitin acid | |
CN114634441B (en) | Method for synthesizing 6, 6-dimethyl-3-azabicyclo [3,1,0] hexane | |
EP2170829B1 (en) | Process for producing toluidine compound | |
CN112250586A (en) | Preparation method of terbutaline sulfate and B crystal form thereof | |
WO2020132820A1 (en) | Synthesis method for 3-(benzyloxy)-4-oxo-4h-pyran-2-carboxylic acid | |
CN108707100B (en) | Irecoxib intermediate and preparation method of Irecoxib | |
CN102180843A (en) | Preparation method of 2-(2-amino-4-thiazolyl)-2(Z)-triphenylmethoxy imidoacetic acid | |
CN114671859B (en) | Preparation method of rosuvastatin calcium and intermediate thereof | |
CN110563726A (en) | Preparation method of tert-butyl-7, 9-dioxy-2, 6-diazaspiro [4.5] decane-2-formic acid ester | |
CN112898152B (en) | Preparation method of ethoxy diethyl methylene malonate | |
CN110551123A (en) | Preparation method of 5- (tert-butyloxycarbonyl) -2-methyl-4, 5,6, 7-tetrahydro-2H-pyrazolo [4,3-C ] pyridine-7-carboxylic acid | |
CN110734364B (en) | Synthesis method of 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone | |
CN109476591B (en) | Process for the preparation of intermediates for 6-arylaminopyridone carboxamide MEK inhibitor compounds | |
CN114315588B (en) | Preparation method of o-nitrobenzaldehyde | |
CN111635358A (en) | Preparation method of hydroxychloroquine | |
CN114989075B (en) | Preparation method of etoricoxib intermediate | |
CN110922355A (en) | Preparation method of nicorandil | |
CN104245692B (en) | For preparing the commercial run of high-purity METHIOZOLIN | |
KR100856133B1 (en) | Improved process for preparing atorvastatin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18944360 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18944360 Country of ref document: EP Kind code of ref document: A1 |